HealthMigraine Prevention Drug Receives FDA Approval: Aimovig By Amgen Is The First Of Its Kind Aimovig, designed for long-term migraine prevention, will now go on sale after receiving approval from the U.S. Food and Drug Administration. The drug is the first of its kind, and it could soon mean the end of chronic migraines.by Aaron Mamiit
HealthAmgen Cholesterol Drug And Statin Combo Reduces Plaque Buildup In Arteries Of Heart Patientsby Rhodi Lee
Healthy Living/WellnessDrug Company Amgen Launches Online Journal For Studies That Attempt To Replicate Experimental Resultsby Angela Laguipo
Healthy Living/WellnessAmgen Cholesterol Drug Repatha Turned Down By UK Cost Watchdogby Rina Marie Doctor
Healthy Living/WellnessFDA Gives Approval To Amgen Melanoma Drug That Uses Herpes Virus To Fight Cancerby Katherine Derla
Healthy Living/WellnessAmgen's Virus-Based Cancer Drug Wins Green Light From EU Regulatorsby Ted Ranosa
Healthy Living/WellnessExpress Scripts Allots 750 Million To Cover Amgen And Sanofi Cholesterol Drugsby Rina Marie Doctor
Healthy Living/WellnessAmgen Opts To Pay $71 Million For Drug Promotion Case Settlementby Rina Marie Doctor
Healthy Living/WellnessNew Drug May Soon Deal With Migraines Before They Even Happenby Rina Marie Doctor